Skip to content

Tiaochang Xiaoliu Granules prevent the recurrence of colorectal adenomas: a multi-center, randomized, controlled study

Tiaochang Xiaoliu Granules prevent the recurrence of colorectal adenomas: a multi-center, randomized, controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035257
Enrollment
Unknown
Registered
2020-08-05
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal adenoma

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged from 40 to 70 years old,either sex; (2) Patients meets the diagnostic criteria of colorectal adenoma,and the number of adenomas between 1 and 6; (3) The pathological diagnosis was tubular adenoma, villous adenoma and villous tubular mixed adenoma; (4) All patients with colorectal adenoma have been treated with endoscopic therapy, and no residual, and within 1 month after surgery. (5) The subjects were informed and voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with colorectal cancer (including early cancer and invasive cancer) or history of colorectal cancer. (2) Patients with ulcerative colitis, Crohn's disease and other inflammatory bowel diseases. (3) Women who are pregnant or preparing for pregnancy, a lactating woman. (4) Patients with severe cardiovascular, pulmonary and cerebrovascular diseases, liver and renal insufficiency (ALT and AST are 2 times higher than the upper limit of normal value in the laboratory of the center; serum creatinine and urea nitrogen are 1.5 times higher than the upper limit of normal value in the laboratory of the center), and can not tolerate colonoscopy treatment and clinical intervention. (5) Allergic constitution, such as allergic history to two or more drugs or things; or known to be allergic to the ingredients of the drug. (6) Serious mental illness. (7) Suspected or confirmed history of alcohol and drug abuse. (8) Frequent changes in the working environment or other circumstances may easily lead to loss of follow-up. (9) Drugs (aspirin, folic acid, vitamin D, calcium, etc.) with potential treatment for colorectal adenomas have been used. (10) Participants in other clinical trials in recent 3 months.

Design outcomes

Primary

MeasureTime frame
Adenoma Detection Rate;

Secondary

MeasureTime frame
Number of adenomas;Location of adenomas;Pathological characteristics of adenoma;Polyp detection rate;

Countries

China

Contacts

Public ContactBeiping Zhang

Guangdong Provincial Hospital of Traditional Chinese Medicine

doctorzbp@163.com+86 13602762766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026